Literature DB >> 8166684

Ligand (T3) dependent and independent effects of thyroid hormone receptors upon human TRH gene transcription in neuroblastoma cells.

P Feng1, Q L Li, T Satoh, J F Wilber.   

Abstract

Thyrotropin releasing hormone (TRH) gene is regulated negatively at the transcriptional level by thyroid hormone (T3) in rat anterior hypothalamus. The actions of T3 upon other target genes are known to be mediated through the thyroid hormone receptors (TR), TR alpha and TR beta. To explore whether the inhibitory regulation of human (h) TRH gene transcription by T3 is TR isoform specific and whether TRH gene transcription can be modulated as well by unliganded TR isoforms, transient gene expression studies have been carried out using hTRH-luciferase (TRH-Luc) chimeric constructs and TR expression constructs, co-transfected into a human neuroblastoma cell line (HTB-11). Data herein demonstrate T3-dependent inhibitory regulation of the hTRH gene promoter by TR-T3 complexes. Moreover, significant inhibition (39%-60%) could be achieved by T3 bound to either hTR alpha 1, hTR beta 1, or rTR beta 1, beta 2 and was comparable quantitatively, indicating an absence of TR isoform specificity for T3 inhibition. Conversely, basal promoter activity of the hTRH gene could be activated significantly by unliganded hTR alpha 1, beta 1, rTR beta 1, and beta 2 (150% to 334%), but not by hTR alpha 2. Thus, TRs appear to exert opposite effects on hTRH gene transcription, depending on the presence or absence of ligand (T3). These dual effects of TR suggest that the addition of the T3 ligand effects conformational changes that can abrogate the initiation of transcription.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8166684     DOI: 10.1006/bbrc.1994.1430

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  M-protein is down-regulated in cardiac hypertrophy driven by thyroid hormone in rats.

Authors:  Andrei Rozanski; Ana Paula C Takano; Patricia N Kato; Antonio G Soares; Camilo Lellis-Santos; Juliane Cruz Campos; Julio Cesar Batista Ferreira; Maria Luiza M Barreto-Chaves; Anselmo S Moriscot
Journal:  Mol Endocrinol       Date:  2013-10-31

2.  Localization of thyroid hormone receptor beta2 in the ventral medullary neurons that synthesize thyrotropin-releasing hormone.

Authors:  P Q Yuan; H Yang
Journal:  Brain Res       Date:  2000-06-16       Impact factor: 3.252

3.  Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone.

Authors:  T Tagami; L D Madison; T Nagaya; J L Jameson
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

4.  Different functions for the thyroid hormone receptors TRalpha and TRbeta in the control of thyroid hormone production and post-natal development.

Authors:  K Gauthier; O Chassande; M Plateroti; J P Roux; C Legrand; B Pain; B Rousset; R Weiss; J Trouillas; J Samarut
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

5.  Increased sensitivity to thyroid hormone in mice with complete deficiency of thyroid hormone receptor alpha.

Authors:  P E Macchia; Y Takeuchi; T Kawai; K Cua; K Gauthier; O Chassande; H Seo; Y Hayashi; J Samarut; Y Murata; R E Weiss; S Refetoff
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

6.  A coregulator shift, rather than the canonical switch, underlies thyroid hormone action in the liver.

Authors:  Yehuda Shabtai; Nagaswaroop K Nagaraj; Kirill Batmanov; Young-Wook Cho; Yuxia Guan; Chunjie Jiang; Jarrett Remsberg; Douglas Forrest; Mitchell A Lazar
Journal:  Genes Dev       Date:  2021-02-18       Impact factor: 11.361

7.  G ATA2 mediates the negative regulation of the prepro-thyrotropin-releasing hormone gene by liganded T3 receptor β2 in the rat hypothalamic paraventricular nucleus.

Authors:  Go Kuroda; Shigekazu Sasaki; Akio Matsushita; Kenji Ohba; Yuki Sakai; Shinsuke Shinkai; Hiroko Misawa Nakamura; Satoru Yamagishi; Kohji Sato; Naoko Hirahara; Yutaka Oki; Masahiko Ito; Tetsuro Suzuki; Takafumi Suda
Journal:  PLoS One       Date:  2020-11-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.